Trial Profile
A study examining the experiences of patients with metastatic castration resistant prostate cancer treated with abiraterone acetate
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 01 Sep 2015 New trial record